Health ❯ Healthcare ❯ Clinical Research

Phase 1 Trials

Safety and Efficacy Efficacy Studies Nimacimab Patient Outcomes Dose Escalation Studies Phase 2 Trials

Wave Life Sciences Shares Plunge 30% After Early Obesity Trial Readout

The readout showed a 14% placebo-adjusted drop in visceral fat with a clean safety profile in a lighter cohort.

Pliant’s PLN-101095 With Keytruda Shows Early Responses in PD-1–Refractory Solid Tumors

Novo Nordisk's Amycretin Pill Shows Promising Weight Loss Results in Early Trial